A Form 4 filed on September 11, 2026, reports that Mark Christopher Capone, a director of Mesa Laboratories Inc /CO/, was awarded 2,423 restricted stock units on September 9, 2026.

Key Highlights

  • Reporting person: Mark Christopher Capone, listed as a Director of Mesa Laboratories Inc /CO/
  • Security awarded: 2,423 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock
  • Transaction date: September 9, 2026, with the form filed September 11, 2026
  • Price of derivative security: $0, as disclosed in the filing
  • Vesting date: RSUs vest on September 9, 2027, according to the filing
  • Beneficial ownership following transaction: 2,423 derivative securities, held directly

Mesa Laboratories Director Mark Capone Granted RSUs Vesting in 2027

According to the Form 4 filed with the U.S. Securities and Exchange Commission, Mark Christopher Capone, a Director of Mesa Laboratories Inc /CO/ (NASDAQ:MLAB), acquired 2,423 restricted stock units on September 9, 2026. The transaction code recorded is "A," indicating an acquisition. The filing was signed by John Sakys under Power of Attorney by Mark Capone and dated September 11, 2026.

The filing discloses that each RSU represents a contingent right to receive one share of the issuer's Common Stock. The price of the derivative security is listed as $0. According to the filing, the RSUs are scheduled to vest on September 9, 2027, with the expiration date field marked as "Not Applicable." Following the reported transaction, Capone beneficially owns 2,423 RSUs directly, with no indirect ownership reported.

No non-derivative securities transactions were reported in Table I of the filing. The filing was made pursuant to Section 16(a) of the Securities Exchange Act of 1934, and no amendment to a prior filing was indicated.

What Was Disclosed

The filing reported a single acquisition of 2,423 RSUs by Director Mark Christopher Capone of Mesa Laboratories Inc /CO/ on September 9, 2026, at a price of $0, with vesting set for September 9, 2027, resulting in direct beneficial ownership of 2,423 RSUs.